SMTL ID : 4d38.1

Structure of bovine endothelial nitric oxide synthase heme domain in complex with (1R,2R)-2-(3-fluorobenzyl)-N-{2-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]ethyl}cyclopropanamine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 19 residues within 4Å: Chain A: W.141, A.144, R.146, C.147, V.148, G.149, L.156, S.189, F.316, S.317, G.318, W.319, M.321, E.324, W.410, F.436, Y.438 Ligands: H4B.2, L5Z.3 23 PLIP interactions: 23 interactions with chain A, Hydrophobic interactions: A:W.141, A:W.141, A:W.141, A:A.144, A:R.146, A:L.156, A:F.316, A:F.316, A:F.316, A:F.316, A:W.319, A:E.324, A:W.410, A:W.410, A:F.436, A:F.436, A:F.436 Hydrogen bonds: A:Y.438 Water bridges: A:R.146, A:E.324 Salt bridges: A:R.146 pi-Stacking: A:W.141 Metal complexes: A:C.147 HEM.7: 21 residues within 4Å: Chain B: W.141, A.144, R.146, C.147, V.148, G.149, L.156, S.189, M.302, F.316, S.317, G.318, W.319, M.321, E.324, V.381, W.410, F.436, Y.438 Ligands: H4B.8, L5Z.9 22 PLIP interactions: 22 interactions with chain B, Hydrophobic interactions: B:W.141, B:W.141, B:W.141, B:A.144, B:R.146, B:L.156, B:F.316, B:F.316, B:F.316, B:F.316, B:W.319, B:E.324, B:V.381, B:W.410, B:W.410, B:F.436, B:F.436, B:F.436 Water bridges: B:R.146 Salt bridges: B:R.146 pi-Stacking: B:W.141 Metal complexes: B:C.147

2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)

H4B.2: 12 residues within 4Å: Chain A: S.65, V.67, R.328, A.409, W.410 Chain B: W.408, F.423, H.424, Q.425, E.426 Ligands: HEM.1, GOL.5 8 PLIP interactions: 7 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:R.328, A:A.409, A:W.410 Water bridges: A:R.328 pi-Stacking: A:W.410, A:W.410 pi-Cation interactions: A:W.410 Hydrophobic interactions: B:E.426 H4B.8: 11 residues within 4Å: Chain A: W.408, F.423, Q.425, E.426 Chain B: S.65, V.67, R.328, A.409, W.410 Ligands: HEM.7, GOL.11 8 PLIP interactions: 1 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:E.426 Hydrogen bonds: B:R.328, B:R.328, B:A.409, B:W.410 pi-Stacking: B:W.410, B:W.410 pi-Cation interactions: B:W.410

2 x L5Z: (1R,2R)-2-(3-fluorobenzyl)-N-{2-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]ethyl}cyclopropanamine(Non-covalent)

L5Z.3: 12 residues within 4Å: Chain A: V.67, L.68, Q.210, P.297, V.299, G.318, E.324, W.410, Y.438 Chain B: W.37 Ligands: HEM.1, GOL.5 6 PLIP interactions: 5 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:V.67, A:L.68, A:W.410, B:W.37 Hydrogen bonds: A:E.324 pi-Stacking: A:F.316 L5Z.9: 11 residues within 4Å: Chain A: W.37 Chain B: V.67, L.68, Q.210, P.297, V.299, F.316, E.324, Y.438 Ligands: HEM.7, GOL.11 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:V.67, B:L.68, A:W.37 pi-Stacking: B:F.316

2 x ACT: ACETATE ION(Non-functional Binders)

ACT.4: 5 residues within 4Å: Chain A: G.149, I.151, W.319, V.381, S.389 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.151 Hydrogen bonds: A:W.319, A:S.389 ACT.10: 5 residues within 4Å: Chain B: I.151, Q.152, W.319, V.381, S.389 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:I.151, B:Q.152, B:W.319 Hydrogen bonds: B:S.389, B:S.389

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.5: 6 residues within 4Å: Chain A: V.67, R.328, H.334 Chain B: W.37 Ligands: H4B.2, L5Z.3 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.328, A:R.328 GOL.11: 5 residues within 4Å: Chain B: V.67, R.328, H.334 Ligands: H4B.8, L5Z.9 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:R.328 Water bridges: A:H.424

1 x ZN: ZINC ION(Non-covalent)

ZN.6: 4 residues within 4Å: Chain A: C.57, C.62 Chain B: C.57, C.62 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Metal complexes: A:C.57, A:C.62, B:C.57, B:C.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mukherjee, P. et al., Novel 2,4-Disubstituted Pyrimidines as Potent, Selective, and Cell-Permeable Inhibitors of Neuronal Nitric Oxide Synthase. J.Med.Chem. (2015)

Release Date

2014-12-24

Peptides

NITRIC OXIDE SYNTHASE, ENDOTHELIAL: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

NITRIC OXIDE SYNTHASE, ENDOTHELIAL

Related Entries With Identical Sequence